Clarus Therapeutics Holdings, Inc. SC 13G and SC 13G/A reports

Location
355 S. Grand Avenue, Suite 1450, Los Angeles, CA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
7/19/2024, 08:53 AM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report Feb 14, 2023
SC 13G/A Report SC 13G/A Jul 6, 2022
SC 13G Report SC 13G Feb 15, 2022
SC 13G/A Report SC 13G/A Feb 14, 2022
SC 13G/A Report Feb 14, 2022
SC 13G/A Report SC 13G/A Feb 14, 2022
SC 13G/A Report Feb 14, 2022
SC 13G/A Report BLUWU 13G/A Feb 8, 2022
SC 13G/A Report Feb 4, 2022
SC 13G/A Report KARPUS INVESTMENT MGT / BLUE WATER ACQUISITION - SCHEDULE 13G/A(#1) Oct 8, 2021
SC 13G Report SC 13G Sep 24, 2021
SC 13G Report SC 13G Sep 17, 2021
SC 13G/A Report SCHEDULE 13G/A (AMENDMENT) Aug 27, 2021
SC 13G Report Aug 13, 2021
SC 13G Report SCHEDULE 13G Aug 9, 2021
SC 13G Report KARPUS INVESTMENT MGT / BLUE WATER ACQUISITION - SCHEDULE 13G May 10, 2021
SC 13G/A Report Feb 12, 2021
SC 13G Report SCHEDULE 13G Feb 12, 2021
SC 13G Report SCHEDULE 13G Feb 11, 2021
SC 13G Report BLUWU 13G Feb 8, 2021
SC 13G Report 13G/A Feb 8, 2021
SC 13G Report Dec 23, 2020
SC 13G Report SC 13G Dec 22, 2020